Literature DB >> 16364894

Spinal muscular atrophy: a deficiency in a ubiquitous protein; a motor neuron-specific disease.

Umrao R Monani1.   

Abstract

Spinal muscular atrophy (SMA) is a neurodegenerative disease in humans and the most common genetic cause of infant mortality. The disease results in motor neuron loss and skeletal muscle atrophy. Despite a range of disease phenotypes, SMA is caused by mutations in a single gene, the Survival of Motor Neuron 1 (SMN1) gene. Recent advances have shed light on functions of the protein product of this gene and the pathophysiology of the disease, yet, fundamental questions remain. This review attempts to highlight some of the recent advances made in the understanding of the disease and how loss of the ubiquitously expressed survival of motor neurons (SMN) protein results in the SMA phenotype. Answers to some of the questions raised may ultimately result in a viable treatment for SMA.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16364894     DOI: 10.1016/j.neuron.2005.12.001

Source DB:  PubMed          Journal:  Neuron        ISSN: 0896-6273            Impact factor:   17.173


  137 in total

1.  Antisense oligonucleotides shed new light on the pathogenesis and treatment of spinal muscular atrophy.

Authors:  Jiing-Kuan Yee; Ren-Jang Lin
Journal:  Mol Ther       Date:  2012-01       Impact factor: 11.454

Review 2.  Spinal muscular atrophy: new and emerging insights from model mice.

Authors:  Gyu-Hwan Park; Shingo Kariya; Umrao R Monani
Journal:  Curr Neurol Neurosci Rep       Date:  2010-03       Impact factor: 5.081

Review 3.  Developments in RNA splicing and disease.

Authors:  Michael G Poulos; Ranjan Batra; Konstantinos Charizanis; Maurice S Swanson
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-01-01       Impact factor: 10.005

4.  Reorganization of Cajal bodies and nucleolar targeting of coilin in motor neurons of type I spinal muscular atrophy.

Authors:  Olga Tapia; Rocío Bengoechea; Ana Palanca; Rosa Arteaga; J Fernando Val-Bernal; Eduardo F Tizzano; María T Berciano; Miguel Lafarga
Journal:  Histochem Cell Biol       Date:  2012-02-01       Impact factor: 4.304

5.  Targeted axonal import (TAxI) peptide delivers functional proteins into spinal cord motor neurons after peripheral administration.

Authors:  Drew L Sellers; Jamie M Bergen; Russell N Johnson; Heidi Back; John M Ravits; Philip J Horner; Suzie H Pun
Journal:  Proc Natl Acad Sci U S A       Date:  2016-02-17       Impact factor: 11.205

6.  Non-aggregating tau phosphorylation by cyclin-dependent kinase 5 contributes to motor neuron degeneration in spinal muscular atrophy.

Authors:  Nimrod Miller; Zhihua Feng; Brittany M Edens; Ben Yang; Han Shi; Christie C Sze; Benjamin Taige Hong; Susan C Su; Jorge A Cantu; Jacek Topczewski; Thomas O Crawford; Chien-Ping Ko; Charlotte J Sumner; Long Ma; Yong-Chao Ma
Journal:  J Neurosci       Date:  2015-04-15       Impact factor: 6.167

7.  Regulation of Fasciclin II and synaptic terminal development by the splicing factor beag.

Authors:  Erin S Beck; Gabriel Gasque; Wendy L Imlach; Wei Jiao; Ben Jiwon Choi; Pao-Shu Wu; Matthew L Kraushar; Brian D McCabe
Journal:  J Neurosci       Date:  2012-05-16       Impact factor: 6.167

8.  Multiple effects of curcumin on promoting expression of the exon 7-containing SMN2 transcript.

Authors:  Dairong Feng; Yi Cheng; Yan Meng; Liping Zou; Shangzhi Huang; Jiuyong Xie
Journal:  Genes Nutr       Date:  2015-09-19       Impact factor: 5.523

9.  Inhibition of U snRNP assembly by a virus-encoded proteinase.

Authors:  Laura L Almstead; Peter Sarnow
Journal:  Genes Dev       Date:  2007-05-01       Impact factor: 11.361

Review 10.  Mechanisms of alternative splicing regulation: insights from molecular and genomics approaches.

Authors:  Mo Chen; James L Manley
Journal:  Nat Rev Mol Cell Biol       Date:  2009-09-23       Impact factor: 94.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.